GLP-1 weight-loss drugs like Novo Nordisk's (NVO) Ozempic could be causing a spike in your health insurance costs. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Wealth! to break down the details and how you can expect your insurance to increase in 2025.

For more expert insight and the latest market action, click here to watch this full episode of Wealth!

This post was written by Melanie Riehl